When it comes to life-threatening diseases, we are one family.
We are Kiadis, a biopharmaceutical company who focusses on the treatments of blood cancers aiming to make bone marrow transplantations, safer and more efficient.
Here at Kiadis we are re-imagining medicine by leveraging the natural strengths of humanity and our collective immune systems to source the best cells for life!
Our uncompromising approach to serve patients, their families and care givers aims to minimize harm and maximize help – delivering personalized treatments for every single patient to offer hope, reduce suffering and provide new life.
We are currently expanding and building a new laboratory and manufacturing facility on the Paasheuvelweg in Amsterdam and are looking for a Manager QC to manage the Quality Control team. Do you have the experience we need to manage our QC laboratories in our new Laboratory in Amsterdam?
As Quality Control Manager at Kiadis Pharma, you will:
The ideal candidate
What are we offering in return
Of course, you will receive a competitive salary with short and long term incentive schemes, generous holidays and a flexible working environment. But besides that, you will get the amazing opportunity to get to join a fast-growing and innovative global biotechnology family where you are able to make your own mark within the organization.
For further questions and/or information, please send an email to firstname.lastname@example.org
Note to External Recruiters: All candidate activity and open positions are managed strictly through our Talent Acquisition Department. We kindly request that recruiters do not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Submission of unsolicited resumes prior to an agreement set in place between the Talent Acquisition Department and the recruiting agency will not create any implied obligation.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer and more effective for patients. Kiadis Pharma believes that its innovative products have the potential to address the current risks and limitations connected with allogeneic hematopoietic stem cell transplantation (HSCT), thereby meeting a significant unmet medical need with its products.More about Kiadis Pharma